This is the authors' abstract. We don't add key points for this paper.
Significance Complement system activation occurs in sickle cell disease and other hemolytic disorders, but the pathological relevance and the acquisition of a complement-activating phenotype by host cells during hemolysis remain unclear. Here we demonstrated that intravascular hemolysis triggered liver damage, which was attenuated in C3-deficient mice or by C5 blockade, showing the importance of complement system for hemolysis-mediated tissue stress response. Heme-dependent complement deposits were detected on endothelium, appeared upon activation of TLR4, and were mediated by P-selectin. This resulted in unconventional complement activation, mediated by anchoring of C3(H 2 O) on endothelial surface. In conclusion, our data suggest that complement system could be a therapeutic target in hemolytic diseases, such as sickle cell disease.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Merle et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: